Related Experiment Video

Updated: Jun 2, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Targeting receptor tyrosine kinase pathways in hepatocellular carcinoma

Hung Huynh1, Richard Wei Jie Ong, Peter Yi Qing Li

  • 1Laboratory of Molecular Endocrinology, Division of Molecular and Cellular Research, National Cancer Centre, Singapore. cmrhth@nccs.com.sg

Anti-Cancer Agents in Medicinal Chemistry
|May 11, 2011
PubMed

Insights

Hepatocellular cancer (HCC) treatments need improvement. Emerging tyrosine kinase inhibitors and combination therapies show promise for treating advanced HCC, potentially increasing survival and quality of life.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Hepatocellular cancer (HCC) is a leading cause of cancer death globally.
  • Dysregulated growth factor signaling pathways are key drivers of HCC progression, including angiogenesis, proliferation, and metastasis.
  • Current treatments like sorafenib offer limited survival benefits and face resistance.

Purpose of the Study:

  • To review preclinical and clinical data on novel tyrosine kinase inhibitors (TKIs) for HCC.
  • To explore the rationale and potential of combination therapies for advanced HCC.
  • To identify strategies for improving efficacy, reducing toxicity, and enhancing patient outcomes.

Main Methods:

  • Literature review of preclinical studies and clinical trials.
  • Analysis of molecular pathophysiology and signaling pathways in HCC.
  • Evaluation of emerging TKIs and combination treatment strategies.

Main Results:

  • Emerging TKIs demonstrate potential in preclinical and clinical settings for HCC.
  • Combination therapies are being investigated to overcome treatment resistance and improve efficacy.
  • Understanding drug mechanisms is crucial for optimizing treatment regimens.

Conclusions:

  • There is a critical need for novel therapeutic agents and strategies for advanced HCC.
  • Emerging TKIs and rational combination therapies represent promising avenues for improving patient survival and quality of life.
  • Further research into drug mechanisms and combination approaches is essential for advancing HCC treatment.

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery07:25

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Published on: August 18, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...